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Objectives: To assess the impact of a closed-loop electronic prescribing, automated dispensing, barcode
patient identification and electronic medication administration record (EMAR) system on prescribing and
administration errors, confirmation of patient identity before administration, and staff time.
Design, setting and participants: Before-and-after study in a surgical ward of a teaching hospital, involving
patients and staff of that ward.
Intervention: Closed-loop electronic prescribing, automated dispensing, barcode patient identification and
EMAR system.
Main outcome measures: Percentage of new medication orders with a prescribing error, percentage of doses
with medication administration errors (MAEs) and percentage given without checking patient identity. Time
spent prescribing and providing a ward pharmacy service. Nursing time on medication tasks.
Results: Prescribing errors were identified in 3.8% of 2450 medication orders pre-intervention and 2.0% of
2353 orders afterwards (p,0.001; x2 test). MAEs occurred in 7.0% of 1473 non-intravenous doses pre-
intervention and 4.3% of 1139 afterwards (p = 0.005; x2 test). Patient identity was not checked for 82.6% of
1344 doses pre-intervention and 18.9% of 1291 afterwards (p,0.001; x2 test). Medical staff required 15 s
to prescribe a regular inpatient drug pre-intervention and 39 s afterwards (p = 0.03; t test). Time spent
providing a ward pharmacy service increased from 68 min to 98 min each weekday (p = 0.001; t test); 22%
of drug charts were unavailable pre-intervention. Time per drug administration round decreased from 50 min
to 40 min (p = 0.006; t test); nursing time on medication tasks outside of drug rounds increased from 21.1% to
28.7% (p = 0.006; x2 test).
Conclusions: A closed-loop electronic prescribing, dispensing and barcode patient identification system
reduced prescribing errors and MAEs, and increased confirmation of patient identity before administration.
Time spent on medication-related tasks increased.
I
t is widely believed that information technology will
revolutionise prescribing, dispensing and administration of
medication for hospital inpatients.1–3 Electronic prescribing is
often promoted to reduce prescribing errors, and automated
dispensing and barcode scanning are advocated to reduce
medication administration errors (MAEs).1 4–7 Such systems are
also expected to increase efficiency.3 However, most data
demonstrating benefits originate from single-site studies in
the USA,8–12 where systems of medication prescribing and
supply are very different from the UK.
There have been a small number of UK studies on electronic
prescribing, most of which have only one outcome measure13–19
rather than a range of perspectives.20 None have examined the
impact of a ‘‘closed-loop’’ system that includes automated
dispensing, barcode scanning to confirm patient identity and
electronic medication administration records (EMARs). We
have piloted such a system on one UK hospital ward. This paper
presents key aspects of a comprehensive quantitative evalua-
tion; a companion paper21 presents a qualitative evaluation. Our
objectives were to assess the effect of the system on the
prevalence, types and clinical significance of prescribing errors
and MAEs, confirmation of patient identity before administra-
tion and staff time.
METHODS
Setting
The study was conducted in a 28-bed general surgery ward of a
London teaching hospital, with a mean patient stay of 7 days
and 24 admissions per week, 70% of whom were elective.
Scheduled drug rounds took place four times each day with one
round serving half of the ward. One nurse carried out most
medication-related tasks on each half of the ward. The ward
received a pharmacy service typical of that in UK hospitals, with
a daily visit from the ward pharmacist on weekdays and a short
visit on Saturdays. Before the intervention, medication orders
were prescribed on paper drug charts, and medication was
stored in two drug trolleys and stock cupboards. This study was
approved by the Riverside Research Ethics Committee.
Intervention
The intervention (described in more detail in the appendix)
comprised a closed-loop system incorporating electronic pre-
scribing, ward-based automated dispensing, barcode patient
Abbreviations: EMAR, electronic medication administration record; IV,
intravenous; MAE, medication administration error; OE, opportunities for
error
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identification and EMARs (ServeRx V.1:13: MDG Medical,
Israel). The system went live in June 2003. Only intravenous
(IV) infusions and oral anticoagulants remained on paper
charts.
Study design
We used a before-and-after design, collecting data on all
outcome measures 3–6 months before and 6–12 months after
the intervention. Pre-intervention data on several outcome
measures had to be collected simultaneously to complete data
collection before implementation. Post-intervention data were
collected for each outcome measure in turn.
Prescribing errors
The same ward pharmacist identified prescribing errors on the
study ward during a 4-week period using established defini-
tions,22 classification23 and methods.23 In addition, the principal
investigator (BDF) checked for prescribing errors once a week
to help identify any error that had not been documented by the
ward pharmacist. We recorded whether or not errors were
rectified before the patient received any doses, avoiding the first
2 months after a change of junior medical staff. The denomi-
nator was the estimated number of medication orders written
during each study period. This estimate was based on counting
the number of medication orders written for all patients for
whom health records could be retrospectively retrieved, and
then extrapolating to the total number of patients on the ward
during the study period.23 The potential severity of the errors
was assessed by five judges on a scale from 0 (no harm) to 10
(death) based on a method validated previously;24 the mean
severity score was calculated for each error.
Medication administration errors and checking patient
identity
Pharmacists observed a sample of 56 drug rounds (including
nights and weekends) during a 2-week period using established
methods.25 26 The denominator was the number of opportunities
for error (OE), defined as all doses administered plus any doses
omitted that we could classify as either correct or incorrect.
Each IV dose potentially comprised two OEs, one for prepara-
tion and another for administration.26 An MAE was defined as
any dose of medication that deviated from the patient’s current
medication orders; timing and documentation errors were
excluded. The potential severity of the MAEs identified was
assessed by four judges.24
For each patient to whom medication was administered, we
recorded whether or not their identity was checked.
Staff time
We observed doctors prescribing inpatient medication orders
and calculated the mean time per medication order. The ward
pharmacist self-reported the time taken to provide a clinical
pharmacy service to the study ward each weekday for 4 weeks.
To assess nursing time, the time required to carry out each
scheduled non-IV drug round was recorded during the MAE
study. We then used activity sampling27 to evaluate the
proportion of nursing time spent on medication-related
activities in between scheduled drug rounds. Ten data collec-
tion periods, each of about 2 h, were selected both pre-
intervention and post-intervention, on different days and
shifts, during which a research pharmacist shadowed the nurse
responsible for medication-related activities on one half of the
ward. A signalling device (JD-7, Divilbiss electronics, Chanute,
Kansas, USA) was used to identify 32 random time samples
each hour when the nurse’s activity was recorded.
Sample size calculation and statistical analysis
The primary outcome measures were the prescribing error rate
and MAE rate. To identify a reduction in the prescribing error rate
from 2%23 to 1%, we required 2319 newly written medication
orders in each phase of the study. To identify a reduction in MAEs
from 5%28 to 2.5%, we required 906 OEs in each phase; we
estimated that observation of 56 drug rounds would achieve this.
Both calculations were based on two-sided tests using a of 0.05
and b of 0.2. Nominal data were compared using the x2 test and
continuous data by the unpaired t test; 95% confidence intervals
(CI) were calculated for parametric differences.






Patients on ward for some or all of study period 129 147 –
Patients for whom health records retrieved
(% of all patients)
113 (88) 126 (86) p = 0.78; x2 test
Extrapolated number of medication orders
written for all patients
2450 2353 –
Median number of medication orders per patient
during study period
16 10 p = 0.009; Mann–
Whitney U test
Prescribing errors
Prescribing errors identified (% of projected
number of medication orders written)
93 (3.8) 48 (2.0) p = 0.0004; x2 test
Errors rectified before dose given (% of
prescribing errors)
45 (48) 32 (67) p = 0.06; x2 test
Mean severity score 4.2 4.6 p = 0.24; unpaired t test
Table 2 Prescribing errors presented according to the
stage of the prescribing process






number of errors (%
of medication orders)
Need for drug treatment 20 (0.8) 12 (0.5)
Select specific drug 2 (0.1) 0
Select drug dose 45 (1.8) 29 (1.2)
Select formulation 3 (0.1) 5 (0.2





10 (0.4) 2 (0.1)
Total 93 (3.8) 48 (2.0)
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RESULTS
Prescribing errors
Table 1 presents the medication orders written and prescribing
errors recorded, and table 2 presents the types of error.
The prescribing error rate fell from 93 (3.8%) of 2450
medication orders to 48 (2.0%) of 2353 (95% CI 20.9% to
22.7%), with no change in their mean clinical severity. Table 3
gives examples. More errors were resolved before the patient
received any doses (48% pre-intervention; 67% post-interven-
tion), although not statistically significant.
MAEs and checking patient identity
We observed 56 drug rounds (1644 OEs) pre-intervention, and
55 (1178 OE) afterwards. MAEs fell from 141 pre-intervention
(8.6%) to 53 afterwards (4.4%), a difference of 24.2% (95% CI
22.4% to 26.0%; p = 0.0003). Table 3 gives examples. MAE
rates were highest for IV doses, mainly involving excessively
fast administration of IV bolus doses. Fewer IV OE were
observed post-intervention (171 pre-intervention and 39 post-
intervention), since EMARs allow one nurse to prepare IV
medication while another administers oral medication. Since
this change in working in practice biased the results, we
calculated the MAE rate for non-IV doses. This fell from 7.0%
pre-intervention to 4.3% post-intervention (95% CI 20.9% to
24.5%; p = 0.005). Table 4 presents types of MAE; three of five
wrong dose MAEs post-intervention involved medication stored
outside the automated cabinet such as salbutamol nebules. The
post-intervention wrong route errors were paracetamol given
orally when the rectal route was prescribed and vice versa. The
mean severity score for all MAEs identified pre-intervention was
2.7; post-intervention it was 2.5 (p = 0.39). Patient identity was
not checked before administration for 1110 (82.6%) of 1344 doses
pre-intervention and 244 (18.9%) of 1291 afterwards (p, 0.001);
a difference of 63.7% (95% CI 60.8% to 66.6%).
Staff time
We timed the prescribing of 32 regular inpatient medication
orders pre-intervention and 15 afterwards. Prescribing took a
mean of 15 s per medication order pre-intervention and 39 s post-
intervention (p = 0.03), a difference of 24 s (95% CI 3 to 45).
The time taken to provide a weekday ward pharmacy service
to the study ward rose from a mean of 68–98 min each day (p
= 0.001); this included additional screening of medication
orders from the dispensary-based terminal each afternoon. Pre-
intervention, 78% of patients’ drug charts were available each
day (mean time per chart 3 min, 7 s). Post-intervention, all
records could be accessed (mean time per chart 3 min 30 s).
Table 5 shows the results relating to nursing time. Drug rounds
were quicker, but a higher percentage of time was spent on
medication-related tasks in between drug rounds (an increase of
7.6%; 95% CI 2.4% to 12.8%). This included scheduling newly
prescribed medication for the appropriate drug rounds and
administering the medication prescribed when required.
DISCUSSION
The intervention almost halved prescribing and administration
errors, dramatically increased the checking of patient identity,
and may have resulted in more prescribing errors being
corrected before the patient received any doses. However, these
gains were achieved at the cost of an increase in staff time on
medication-related tasks.
Impact on medication safety
The intervention reduced prescribing errors by 47%, from 3.8%
to 2.0%. An absolute reduction of 1.8% is in line with the 1.9%
reduction (from 6.7% to 4.8%) in an UK critical care study,19
Table 3 Examples of prescribing and administration errors identified
Pre-intervention Post-intervention
Prescribing errors (stage of drug use process)
l Patient usually takes simvastatin 20 mg at night, but not prescribed on admission
(need for drug treatment)
l Tinzaparin and enoxaparin prescribed together when only one was
needed (need for drug treatment)
l ‘‘Vitamin B12 co strong’’ prescribed when ‘‘vitamin
B tablets compound strong’’ intended (select specific drug)
l Cyclizine 50 mg tablets prescribed to be given once an hour, instead
of once every 8 h, when required (select drug dose)
l Bendroflumethiazide 20 mg once daily prescribed when 5 mg intended (select
drug dose)
l A dose of ciclosporin 150 mg was prescribed to be given using the
100 mg capsules rather than the 50 mg capsules (select formulation)
l Dipyridamole 200 mg twice daily prescribed for secondary prevention of ischaemic
stroke, without specifying that modified release required (select formulation)
l Trimipramine 50 mg four times daily prescribed for a patient who
usually takes 200 mg at night (give administration instructions)
l Beclometasone inhaler prescribed with no strength specified (give instructions for
supply)
l Prednisolone 10 mg prescribed without specifying time or frequency of
administration (give administration instructions)
Administration errors (type of error)
l Levothyroxine 25 mg omitted as could not find medication (omission) l Propranolol 160 mg not given as not available on ward (omission due
to unavailability)
l Thiamine 100 mg prescribed. Observer intervened to prevent levothyroxine 100 mg
being given (wrong drug)
l Salbutamol 5 mg nebule administered when 2.5 mg prescribed
(wrong dose)
l Ciprofloxacin 500 mg administered when 250 mg prescribed (wrong dose) l Administration of Tazocin 4.5 g IV over 30 s instead of 3–5 min (fast
administration IV bolus)
l Norfloxacin 400 mg given twice as first dose was not signed for (extra dose) l Administration of paracetamol 1 g orally when rectal route was
prescribed (wrong route)
IV, intravenous.
Table 4 Medication administration errors identified
Type of error
Pre-intervention No. of
errors (% of OE)
Post-intervention No. of
errors (% of OE)
Wrong drug 2 (0.1) —
Wrong dose 29 (1.8) 5 (0.4)
Wrong patient 5 (0.3) —
Wrong route 2 (0.1) 6 (0.5)
Wrong form — —
Wrong time — 1 (0.1)
Extra dose 2 (0.1) —
Expired drug 1 (0.1) —
Omission due to
unavailability
26 (1.6 25 (2.1)
Other omission 42 (2.6) 11 (0.9)
Wrong diluent 1 (0.1) —
Fast administration
IV bolus
31 (1.9) 5 (0.4)
Total 141 (8.6) 53 (4.4)
IV, intravenous; OE, opportunities for error.
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and supports previous US study9 10 12 data showing that
computerisation can reduce prescribing errors. A further
reduction may be possible with additional decision support.
Our baseline figure of 3.8% was higher than the 1.5% reported
previously across a range of wards using the same definitions
and similar methods.23 This may be partly accounted for by the
additional check by the principal investigator, who recorded
more than a third of the errors in the present study.
The intervention reduced non-IV MAEs by 39%, predominantly
reducing wrong dose and omission errors. Our baseline non-IV
figure of 7.0% is in line with previous UK data.13 28–34 The
improvement is likely to be due to the design of the automated
dispensing system and trolley; instead of a drug trolley containing
many different drugs, strengths and formulations, the system
gives nursing staff access only to the product prescribed. EMARs
also clearly indicate doses due. Electronic prescribing alone has
not been shown to reduce MAEs in the UK.13
The system increased the percentage of doses for which the
patient’s identity was checked before administration. However,
full compliance was not achieved because of informal practices
such as sticking barcodes to patients’ furniture, which were
scanned instead of the patient’s wristband.
Impact on staff t ime
The intervention increased pharmacy and medical staff time.
Nursing time spent on drug rounds decreased, which allowed the
staff more flexibility in planning their time. This was despite
increasing the percentage of patients whose identities were
checked. More time was required for other tasks between drug
rounds. The increase in pharmacist time may be partly due to
more patients’ medication charts being seen each day, as they
were no longer unavailable when patients were in theatre or
having investigations, and partly due to the time required to move
between different screens to approve medication orders or to see a
treatment overview. Our sample size for prescribing times was
small, but the results show that prescribing using the computer
took more time than on a paper chart. The only previous UK study
to explore the impact of electronic prescribing on the time taken to
prescribe included only one medication order pre-intervention
and post-intervention.14 A systematic review has suggested that
electronic ordering generally reduces nursing time but increases
physician time.35 We believe that software changes could reduce
the time spent by all professions.
Strengths and weaknesses of the study
The strengths of our study are that, in contrast with previous
work, we collected data on a range of outcome measures within
a comprehensive evaluation framework.20 We also used
validated methods for identifying and assessing prescribing
and administration errors. This is the first study of a closed-
loop system incorporating automated dispensing and EMARs.
Unlike many US studies,9 10 12 it was a commercial system
rather than one developed in-house.
The main weakness of this study is that generalisability from a
one-ward study, of one version of a product at one point in time, is
limited. There are also practical difficulties in evaluating a system
being piloted on only one ward, which could lead to the system
appearing less effective than it could be; the associated qualitative
study (unpublished data) explores these issues. Our pre-inter-
vention system used traditional drug trolleys rather than
individual patient medicine lockers as now used in many UK
hospitals. However, we were using other aspects of a one-stop
dispensing system;36 a previous study suggests that individual
patient lockers do not reduce MAEs,28 so the lack of these is
unlikely to have affected our results. Finally, in the prescribing
error study, fewer medication orders were written per patient in
the post-intervention period. This is likely to be due to a slight
increase in patient turnover over the time period of the study; the
total number of medication orders written was similar.
Implications
Our study, and a previous UK study of electronic prescribing in
intensive care,19 suggest that when electronic prescribing is first
implemented in hospitals it will stop two errors in every 100
prescriptions written. However, as our associated paper shows,21
this should not be seen as the effectiveness of electronic
prescribing, but as a starting point from which it can be further
developed. The methodology used in these two papers means
that areas for development have been systematically identified
together with reproducible methods with which to measure
progress.
It may be that the errors avoided are those that pharmacists
usually correct, but electronic prescribing ensures that they are
always correct before the first dose is due and has the potential to
allow pharmacists to concentrate on other aspects of the usage of
medicines. However, electronic prescribing is expensive and
economic analyses of this and other types of interventions are
needed. It will be important to estimate the harm avoided by such
systems, which may be disproportional to their reduction in errors.
The combination of electronic prescribing with automated
dispensing, bar coded patient identification and EMARs is
workable and would significantly reduce prescribing and
administration errors.
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APPENDIX A: DESCRIPTION OF THE SYSTEM
The system comprised the following three elements.
Electronic prescribing, scheduling and administration
software
There were two prescribing terminals on the study ward, and
one in the pharmacy department. There were also two hand-
held tablet computers on the study ward, which could be taken
from patient to patient and used to view, prescribe and
discontinue medication orders. These had to be synchronised
with the ward-based server via a docking station before and
after use. The software was Windows based, and the patient
medication screen was intended to resemble an inpatient drug
chart (fig A1). When prescribing, a doctor could access pull-
down lists of all drug products stocked on the ward, all drug
products in the trust’s formulary and all products in the drug
dictionary. Prescribing was by product (aspirin 75 mg soluble
tablets) rather than by drug (aspirin). Default doses were
suggested for most products. No other decision support was
enabled. If the patient had any allergies entered, these were
displayed on the prescribing screen. When patients were
transferred from other wards, pharmacists were authorised to
transcribe their existing medication orders onto the computer
system.
Once drugs had been prescribed, a nurse (or, less often, a
pharmacist or doctor) scheduled the doses to specific drug
round times and indicated the drug round at which the first
dose was to be given.
Pharmacists checked and ‘‘approved’’ medication orders
from a separate pharmacy screen, which highlighted unap-
proved medication orders. Medication orders did not have to be
approved before they could be administered by nursing staff. At
the approval stage, pharmacists could enter additional instruc-
tions relating to administration; further instructions could not
be entered after orders had been approved.
Ward-based automated dispensing
The majority of medication was stored in large automated
cabinets; the doses required were transferred by nursing staff to
an electronic drug trolley at each drug round. The automated
cabinets, containing computer-controlled drawers and a touch-
sensitive computer screen, were situated in the ward’s
treatment room. Products that were ward stock were in
product-specific drawers containing only that drug, dose and
formulation, in original packs. Non-stock medication dispensed
for individual patients was stored in patient-specific drawers,
which could contain several products dispensed for that
patient. The patient’s name was indicated on the drawer using
a liquid crystal display. The computer screen indicated the
patients for whom doses were due in the next 2 h. To prepare
for a drug round, the nurse selected each patient using the
touch-sensitive screen and was then presented with a list of the
doses due. On selecting each dose, the relevant drawer in the
cabinet opened (fig A2) so that the nurse could take the
number of dosage forms required and place these in the
electronic drug trolley.
To restock the cabinet, a pharmacy technician printed a list of
products below the specified reorder level. Barcodes on each
drug product were used to confirm the identity of the
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medication loaded into each drawer. Non-stock medication was
ordered by nursing staff via the ward pharmacist.
Electronic drug trolleys
There were two electronic drug trolleys (fig A3), one for each
half of the ward. Each contained 20 drawers and could be
docked with the automated cabinet. When medication was
being prepared for a drug round, only one drawer in the drug
trolley opened at a time, and the patient’s name was indicated
on the drawer’s liquid crystal display. When all medication for a
given patient had been prepared, the system instructed the
nurse to close that patient’s drawer in the drug trolley before
medication for the next patient could be prepared. Once all
medication had been prepared for a given drug round, the
trolley could be disconnected and taken around the ward. The
barcode on each patient’s wristband was scanned, which
triggered the system to open that patient’s drawer in the trolley
so that the medication could be administered. The nurse
confirmed administration using a touch-sensitive screen on the
trolley, and entered the reasons for any doses not given.
On completion of the drug round, details of all doses
administered and reasons for any omission were uploaded to
the main server once the trolley was docked.
Medication prescribed ‘‘to be given when required’’ was
generally given separately outside the main drug rounds.
Figure A1 Prescribing screen showing active medication orders. The triangles show doses that have not been administered; regular medication is shown in
dark text and medication given when required in light text.
Figure A2 Nurse selecting stock medication from drawer in automated
cabinet. The patient-specific drawers can be seen below the open drawer,
and the screen to the right. Photo published with nurse’s permission.
Figure A3 One of the two electronic drug trolleys. One drawer is
allocated to each patient for whom medication is due and their name
shown on the liquid crystal display. The barcode scanner is on the top of the
trolley.
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